Baker & McKenzie Guides $109M Biocartis IPO
Belgian biotech company Biocartis Group NV pulled in €100 million ($109 million) with an initial public offering advised by Baker & McKenzie LLP on Monday, planning to use the funds to...To view the full article, register now.
Already a subscriber? Click here to view full article